Please login to the form below

Not currently logged in
Email:
Password:

Catalent

This page shows the latest Catalent news and features for those working in and with pharma, biotech and healthcare.

KaloBios files for bankruptcy protection

KaloBios files for bankruptcy protection

Miami and a number of contractors including Lonza, Catalent, INC Research and PPD.

Latest news

  • Vivus expects knockback from EMA for obesity drug Vivus expects knockback from EMA for obesity drug

    Vivus has been concentrating on manufacturing with its partner Catalent and is rolling out the product with the support of contract sales organisation PDI.

  • Craig Collingwood becomes director of finance at Penn Pharma

    This experience includes Collingwood's time as audit manager at KPMG, director of finance and operational excellence at Cardinal Health, and group finance director at Catalent Pharma Solutions.

  • Both feet first

    organisations including Catalent Pharma Solutions, Lonza and Patheon offer comprehensive services that have enabled these organisations to become highly integrated with the life sciences companies they support.

  • CEVEC and Catalent partner on cell lines

    CEVEC and Catalent partner on cell lines. CEVEC Pharmaceuticals and Catalent Pharma Solutions have launched a joint commercial cell line development service for pharma and biotech customers worldwide. ... CEVEC Pharmaceuticals and Catalent Pharma

  • Penn Pharma appoints new CEO

    industry. He has held senior positions including group president of Sterile Technologies at Catalent Pharma Solutions and president for Europe and Asia Pacific at Catalent.

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    to deficiencies at the plant operated by Catalent [its CMO].

  • Deal Watch January 2016 Deal Watch January 2016

    Last up, with a headline value of $619m, is Roche's option deal with Catalent/Redwood. ... 750. Catalent| Redwood Bioscience/ Roche. Research collaboration. Non-exclusive access to Redwood's SMARTag platform with an option to commercial licences to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Catalent

    Catalent. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. ... Telephone:1 888 765 8846. Address:. Catalent Pharma Solutions. 14 Schoolhouse Road Somerset.

  • Research and development

    Research and development. This Research and development section features Research and development companies, inc drug development;. Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare

  • Manufacturing, packaging and logistics

    Catalent Pharma Solutions.

  • Catalent Pharma Solutions

    Catalent Pharma Solutions. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. ... Catalent Pharma Solutions.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics